D-甘露糖 D-Mannose × 下泌尿道症狀

結論:證據支持

Independent grade U (insufficient evidence / not addressed).

C 🟠 C 薄弱證據 已發布 ⚠️ medium — moderate promotional content
⚠️ 標記 🇹🇼 台灣在地警示

Independent grade U (insufficient evidence / not addressed). All five condition-specific layers (L2 PubMed, L5b Mayo Clinic, L5c Cleveland Clinic, L5d Harvard Health, L5e AUA / Urology Care Foundation) converge on the same finding: no RCT, no systematic review, no clinical practice guideline, no major medical authority, and no professional urology society has addressed D-Mannose as an intervention for non-infectious lower urinary tract symptoms (LUTS) such as frequency, urgency, nocturia, or overactive bladder. The mechanism of D-Mannose is FimH-mediated blockade of E. coli adhesion to uroepithelium, which is bacteria-specific and provides no biological rationale for non-infectious LUTS benefit. The largest available RCT (MERIT, JAMA Internal Medicine 2024, n=598) explicitly excluded overactive bladder patients and used UTI episodes — not LUTS — as the primary endpoint. The two LUTS-flavored signals (post-prolapse-surgery combination supplement, post-cystoscopy D-mannose plus S. boulardii) are confounded by combination formulations and post-procedural infection-prevention contexts. Because the evidence base is structurally absent rather than negative, the appropriate independent grade is U (needs more evidence), not D (evidence of no effect).

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.46
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 已發布
信心度
81%
證據方向一致性高
證據層級
E5
單篇大型隨機對照試驗(n≥500)

各層「支持此療效」的程度

分數越低=該層越不支持
L11 AI 複核獨立判讀
0.20
L2 PubMed原始文獻
0.45
L1 Examine國際基準
0.50
L3 機轉生理合理性
0.50
L5 臨床機構權威立場
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.455
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery
PMID: 31674202 2019 隨機對照試驗 n = 96
結論:In postmenopausal women undergoing cystocele surgery, combination supplement improved the filling domain of LUTS questionnaire vs. control; effect not attributable to D-mannose alone (combination product, no monotherapy arm).
🟠 品質有限 效應量:Filling-domain LUTS score improvement (p<0.05); D-mannose contribution unquantifiable
前往 PubMed
D-Mannose Plus Saccharomyces boulardii to Prevent Urinary Tract Infections and Discomfort after Cystoscopy: A Single-Center Prospective Randomized Pilot Study
PMID: 37374369 2023 隨機對照試驗 n = 64
結論:Treatment group had lower median IPSS (10.5 vs. 16.5, p=0.021) and pain score (1.5 vs. 4.0, p=0.012) 7 days post-cystoscopy; effect confounded by S. boulardii co-administration and post-procedural inflammation context (not general LUTS).
🟠 品質有限 效應量:ΔIPSS −6 points (p=0.021)
前往 PubMed
d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial (MERIT)
PMID: 38587819 2024 隨機對照試驗 n = 598
結論:Primary endpoint (UTI episodes) not reduced: 51.0% D-mannose vs. 55.7% placebo, no significant difference. Trial explicitly excluded overactive bladder syndrome patients; LUTS frequency/urgency in absence of infection was not assessed as an outcome.
🟢 高品質 政府資助 效應量:Risk difference −4.7% (95% CI not significant)
前往 PubMed

L4a US FDA
謹慎
Advanced U-Tract consists of D-mannose, which is used to help prevent bacteria from adhering to the walls of the urinary tract and reduce the occurrence of urinary tract infections. ... Therefore, this product is intended for treatment of diseases that are not amenable to self-diagnosis or treatment without the supervision of a licensed practitioner. As such, adequate directions cannot be writt… 來源↗
L4b EU EFSA
反對
L4c UK NHS
謹慎
D-mannose – a sugar you can buy as a powder or tablets to take every day 來源↗
L4d TW TFDA / 衛福部
中性
D-甘露糖屬自然界存在的單糖,為葡萄糖異構體,可以從植物與微生物中獲得,被廣泛應用於食品、化妝品以及醫藥業等領域。 來源↗
L4e WHO
未表態
— 本適應症無對應資料

L5a NIH Office of Dietary Supplements
中性
— 本適應症無對應資料
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
未表態
— 本適應症無對應資料
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 中度
📍立場總覽

台灣社群(PTT WomenTalk/e-shopping、Dcard 女孩板)對反覆泌尿道感染的私密保養討論熱烈,D-甘露糖常與蔓越莓、益生菌一起被討論。整體經驗分歧但傾向:認為甘露糖比單吃蔓越莓更有感,部分反覆發炎者吃了覺得復發減少;但也有不少人(含被引用的醫師發言)認為這類保養品只是輔助、無法治療急性發炎,真正關鍵仍是多喝水、不憋尿、注意衛生與性行為後排尿。多數人把它定位為『保養品概念』而非藥物。

💬社群實感

分歧(甘露糖評價略優於蔓越莓,反覆發炎者多認為有輔助效果;但相當多人與被引用醫師認為僅保養、無法治療,真正關鍵是多喝水不憋尿)

破解迷思 社群最常見的 5 個誤解
事實以為吃蔓越莓或甘露糖就能『治療』急性泌尿道感染,可取代抗生素(實際只能作為預防/保養,急性感染仍需就醫)
事實把蔓越莓與 D-甘露糖混為一談或以為功效相同(兩者機轉不同:蔓越莓 PACs 抑制黏附、甘露糖直接結合大腸桿菌菌毛隨尿排出)
事實誤以為市售一般蔓越莓保健品劑量就足夠,忽略需『足量』甘露糖(約 1500-2000mg/日)才可能有感
事實認為甘露糖對所有泌尿道感染都有效,忽略其主要針對大腸桿菌(E. coli)造成的感染,對其他菌種證據不足
事實以為只要吃保健品就好,輕忽多喝水、不憋尿、性行為後排尿等行為因素才是預防核心
🩹 社群通報的副作用
  • 社群幾乎未提及明顯副作用,多數用戶與被引用醫師表示『沒有壞處、要試也可以』
  • 零星提到高劑量可能腹瀉/稀便(多源自衛教而非社群實測)
  • 較常見的抱怨偏向『價格不便宜、效果因人而異/無感』而非身體不適
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • 大研生醫 淨密樂/舒密樂(蔓越莓+甘露糖+益生菌,社群與業配最常出現)
  • GNC 蔓越莓+甘露糖複合產品
  • Now Foods D-Mannose(國外原裝、代購常見)
  • Costco 蔓越莓產品
  • 阿德比婦寶塞劑(已停代理,改法國代購,常被一併討論)

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

「全台唯一添加 De-UTI® mannose D-甘露糖配方 1000mg,搭配 300 倍高濃縮法國 dianafood 專利蔓越莓萃取物、義大利專利 5 隻益生菌」 NT$552/24 包

代表來源 ↗
L10b · TFDA 法定身份 官方認定

「甘露糖有許多益處,因國內食品法規範,不得聲稱療效」

來源 ↗

  • 行為與生活型態調整
  • alpha 阻斷劑藥物治療
  • 5-alpha 還原酶抑制劑
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 3 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v23 engine_version: v1.0 claim_id: CLM-COND-urinary-symptoms-INT-d-mannose-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-urinary-symptoms-INT-d-mannose-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "D-甘露糖能改善下泌尿道症狀",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}